NeuroGenetic Pharmaceuticals Obtains New Funding

  • Feed Type
  • Date
    1/5/2012
  • Company Name
    NeuroGenetic Pharmaceuticals
  • Mailing Address
    445 Marine View Ave Del Mar, CA 92014
  • Company Description
    NeuroGenetic Pharmaceuticals is a privately held biotech company founded in 2009 with worldwide exclusive rights to a platform of gamma-secretase modulators.
  • Website
    http://www.neurogeneticpharmaceuticals.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The funding will expedite the development of our lead candidate, NGP 555, for the prevention of AD, including achieving our immediate goal of initiating clinical trials.
  • M&A Terms
  • Venture Investor
    Abbott Biotech Ventures

Trending on Xconomy